Senior authors, equal contributors.
ITPA genotype protects against anemia during peginterferon and ribavirin therapy but does not influence virological response
Article first published online: 25 APR 2014
© 2014 by the American Association for the Study of Liver Diseases
Volume 59, Issue 6, pages 2152–2160, June 2014
How to Cite
Holmes, J. A., Roberts, S. K., Ali, R. J., Dore, G. J., Sievert, W., McCaughan, G. W., Crawford, D. H., Cheng, W. S., Weltman, M. D., Bonanzinga, S., Visvanathan, K., Sundararajan, V., Desmond, P. V., Bowden, D. S., Matthews, G. V., Thompson, A. J. and on behalf of the CHARIOT Study Group (2014), ITPA genotype protects against anemia during peginterferon and ribavirin therapy but does not influence virological response. Hepatology, 59: 2152–2160. doi: 10.1002/hep.27022
Potential conflict of interest: Nothing to report.
- Issue published online: 28 MAY 2014
- Article first published online: 25 APR 2014
- Accepted manuscript online: 21 JAN 2014 10:46AM EST
- Manuscript Accepted: 15 JAN 2014
- Manuscript Received: 18 NOV 2013
Additional Supporting Information may be found in the online version of this article at the publisher's website.
|hep27022-sup-0001-supptables.pdf||98K||Supporting Information Tables.|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.